WMG Financial Advisors’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.9K | Hold |
12,605
| – | – | 0.01% | 189 |
|
|
2025
Q1 | $44K | Hold |
12,605
| – | – | 0.02% | 169 |
|
|
2024
Q4 | $41.2K | Hold |
12,605
| – | – | 0.02% | 171 |
|
|
2024
Q3 | $48.5K | Hold |
12,605
| – | – | 0.02% | 175 |
|
|
2024
Q2 | $38.9K | Hold |
12,605
| – | – | 0.02% | 155 |
|
|
2024
Q1 | $32.5K | Hold |
12,605
| – | – | 0.02% | 146 |
|
|
2023
Q4 | $31.5K | Hold |
12,605
| – | – | 0.02% | 125 |
|
|
2023
Q3 | $25.6K | Hold |
12,605
| – | – | 0.02% | 99 |
|
|
2023
Q2 | $29K | Hold |
12,605
| – | – | 0.02% | 123 |
|
|
2023
Q1 | $38.2K | Hold |
12,605
| – | – | 0.03% | 117 |
|
|
2022
Q4 | $29.4K | Hold |
12,605
| – | – | 0.03% | 132 |
|
|
2022
Q3 | $24K | Hold |
12,605
| – | – | 0.02% | 137 |
|
|
2022
Q2 | $34K | Buy |
+12,605
| New | +$34K | 0.03% | 141 |
|